Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Burn eschar refers to the devitalized, necrotic tissue that develops on the surface of the skin following a significant thermal, chemical, or electrical burn (StatPearls, 2023). It is primarily composed of denatured extracellular matrix proteins, particularly collagen, which have undergone coagulative necrosis due to the initial insult (PubMed, PMID: 30243544). Although it may initially act as a temporary physical barrier, the eschar is avascular and serves as a potent medium for microbial growth, increasing the risk of sepsis and inhibiting wound contraction and epithelialization (NIH, 2022). Management of burn eschar is a critical component of burn care, typically involving surgical excision or enzymatic debridement to remove the necrotic layer and prepare the wound bed for grafting or spontaneous healing. Pharmacological agents like bromelain-derived enzymes (e.g., Anacaulase-bcbd) or collagenases are used to selectively liquefy the eschar while sparing viable dermis (FDA, 2022). The removal of eschar is essential to reduce the inflammatory load and prevent the development of burn wound sepsis.
Enzymatic debridement through the selective proteolysis of denatured collagen and other extracellular matrix proteins within the necrotic tissue, facilitating its separation from the viable wound bed.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Burn eschar.